{
     "PMID": "19376075",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20091001",
     "LR": "20161125",
     "IS": "1873-7064 (Electronic) 0028-3908 (Linking)",
     "VI": "57",
     "IP": "1",
     "DP": "2009 Jul",
     "TI": "Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects.",
     "PG": "18-24",
     "LID": "10.1016/j.neuropharm.2009.03.016 [doi]",
     "AB": "Selective serotonin reuptake inhibitors are the most widely prescribed antidepressant drugs. However, they exhibit a slow onset of action, putatively due to the initial decrease in serotonin cell firing mediated via somato-dendritic autoreceptors. Interestingly, blockade of 5-HT(2C) receptors significantly potentiates the effect of citalopram, a selective serotonin reuptake inhibitor, on serotonin efflux in the hippocampus and prefrontal cortex (Cremers, T.I.F.H., Giorgetti, M., Bosker, F.J., Hogg, S., Arnt, J., Mork, A., Honig, G., Bogeso, K.P., Westerink, B.H.C., den Boer, J.A., Wikstrom, H.V., Tecott, L.H., 2004. Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade. Neuropsychopharmacology 29, 1782-1789; Cremers, T.I.F.H., Rea, K., Bosker, F.J., Wikstrom, H.V., Hogg, S., Mork, A., Westerink, B.H.C., 2007. Augmentation of SSRI effects on serotonin by 5-HT(2C) antagonists: mechanistic studies. Neuropsychopharmacology 32, 1550-1557.). Using in vivo electrophysiology, we show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) receptors, indicating a possible contribution of a partial blockade of 5-HT(2A) receptors together with 5-HT(2C) receptors, we suggest that high occupancy at 5-HT(2C) receptors is essential for the blockade of the inhibitory effect of citalopram on 5-HT cell firing. Using microdialysis, we also show that the potentiation by SB242,084 on serotonin efflux requires an action of citalopram outside the terminal, most likely at the somato-dendritic level (i.e., on serotonin cell firing). Further experiments using local 5-HT(2C) receptor blockade indicate a role of 5-HT(2C) receptors located in the prefrontal cortex. Modulation of short or long feedback loops originating in the prefrontal cortex by 5-HT(2C) receptors could directly inhibit serotonin efflux, or alternatively, regulate serotonin cell firing in the dorsal raphe nucleus, thereby modulating serotonin efflux indirectly.",
     "FAU": [
          "Sotty, Florence",
          "Folgering, Joost H A",
          "Brennum, Lise T",
          "Hogg, Sandra",
          "Mork, Arne",
          "Hertel, Peter",
          "Cremers, Thomas I F H"
     ],
     "AU": [
          "Sotty F",
          "Folgering JH",
          "Brennum LT",
          "Hogg S",
          "Mork A",
          "Hertel P",
          "Cremers TI"
     ],
     "AD": "Department of Neurophysiology, H.Lundbeck A/S, Ottiliavej 9, 2500 Copenhagen-Valby, Denmark. fsot@lundbeck.com",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20090417",
     "PL": "England",
     "TA": "Neuropharmacology",
     "JT": "Neuropharmacology",
     "JID": "0236217",
     "RN": [
          "0 (6-chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indoline)",
          "0 (Aminopyridines)",
          "0 (Fluorobenzenes)",
          "0 (Indoles)",
          "0 (Piperidines)",
          "0 (Receptor, Serotonin, 5-HT2C)",
          "0 (Serotonin 5-HT2 Receptor Antagonists)",
          "0 (Serotonin Antagonists)",
          "0 (Serotonin Uptake Inhibitors)",
          "10028-17-8 (Tritium)",
          "333DO1RDJY (Serotonin)",
          "EW71EE171J (volinanserin)"
     ],
     "SB": "IM",
     "MH": [
          "Action Potentials/drug effects/*physiology",
          "Aminopyridines/metabolism",
          "Analysis of Variance",
          "Animals",
          "Dose-Response Relationship, Drug",
          "Drug Synergism",
          "Fluorobenzenes/metabolism",
          "Indoles/metabolism",
          "Male",
          "Microdialysis",
          "Neurons/drug effects/*physiology",
          "Piperidines/metabolism",
          "Protein Binding/drug effects",
          "Raphe Nuclei/*cytology",
          "Rats",
          "Receptor, Serotonin, 5-HT2C/metabolism",
          "Serotonin/metabolism",
          "*Serotonin 5-HT2 Receptor Antagonists",
          "Serotonin Antagonists/pharmacology",
          "Serotonin Uptake Inhibitors/*pharmacology",
          "Tritium/metabolism"
     ],
     "EDAT": "2009/04/21 09:00",
     "MHDA": "2009/10/02 06:00",
     "CRDT": [
          "2009/04/21 09:00"
     ],
     "PHST": [
          "2008/08/04 00:00 [received]",
          "2009/03/18 00:00 [revised]",
          "2009/03/31 00:00 [accepted]",
          "2009/04/21 09:00 [entrez]",
          "2009/04/21 09:00 [pubmed]",
          "2009/10/02 06:00 [medline]"
     ],
     "AID": [
          "S0028-3908(09)00105-1 [pii]",
          "10.1016/j.neuropharm.2009.03.016 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuropharmacology. 2009 Jul;57(1):18-24. doi: 10.1016/j.neuropharm.2009.03.016. Epub 2009 Apr 17.",
     "term": "hippocampus"
}